Cloud Migration

With a hefty war chest and a veteran leadership team, Bleichroeder Acquisition Corp. II launches its search for a high-growth tech company to take public.

Facing a Nasdaq delisting notice, social commerce firm Webuy Global has 45 days to devise a plan to fix its $2.1M stockholders' equity deficiency.

Hong Kong's 3E Network completes a $2M financing round, fueling its strategic shift into the competitive global AI infrastructure market.

Amid a nationwide blackout, Iran selectively restores internet for universities, a move experts call a new phase of state control and surveillance.

VCI Global's new Kuala Lumpur AI Lounge offers subscription access to NVIDIA's top GPUs, aiming to democratize AI and build a future of robotics.

At CES 2026, Samsung unveils a future powered by AI, from a massive 130” Micro RGB TV and 6K 3D gaming to a fully integrated smart home ecosystem.

A massive partnership aims to build gigawatt-scale data centers for OpenAI's 'Stargate' project, merging AI ambition with immense energy demands.

With drug costs soaring, industry veteran Ritu Malhotra joins Illuminate Rx, promising to disrupt the opaque PBM market. But can transparency truly win?

Eason Technology is betting its future on Chinese real estate with a deal that could dilute shareholders by over 80%. But can it get past the NYSE?

Zebra Technologies launches new AI-powered mobile computers and a suite of software solutions, aiming to redefine retail efficiency and empower associates.

As CEO Brian Stading exits after a massive expansion, Lumos elevates internal leaders, pivoting to operational excellence in a fierce fiber broadband market.

Maria Montenegro, an AI and M&A expert, takes the helm of the CP & ESG unit, signaling a major push into tech-driven corporate compliance and performance.

Amazon Pharmacy now offers the new Wegovy pill with transparent cash-pay options, shaking up the high-demand weight management drug market.

Prescryptive and Ilant Health unveil a direct-to-employer model for obesity drugs, promising transparent pricing and better clinical outcomes for employers.

Amid rising regulatory pressure, dxFeed's flawless performance in a critical industry-wide disaster recovery test sets a new benchmark for data reliability.

EpicQuest Education's CES award highlights its AI university plans, but a closer look reveals a complex picture of innovation, market hype, and financial risk.

With a huge new investment, MEDIPOST is advancing its proven stem cell therapy for knee osteoarthritis into a pivotal Phase III trial in the United States.

With new trials in myositis and pediatrics, Cartesian Therapeutics pioneers an outpatient cell therapy, moving beyond cancer to treat chronic autoimmune diseases.

With $82M in funding and novel gene insertion technology, Averna Therapeutics is poised to make waves at the pivotal J.P. Morgan Healthcare Conference.

With record revenue and a bold AI strategy, Opera heads to a key investor conference. Can its 'agentic' browsers redefine the web and win market share?